gian carlo antonini cappellini - Oncologist - Ospedale Sandro Pertini - ASL RM2 | LinkedIn
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma – topic of research paper in Clinical medicine. Download scholarly article PDF
Dr. Stephen B. Baylin, MD | Baltimore, MD | Endocrinologist | US News Doctors
Gian CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI | Oncologia | Research profile
Gabrielé hi-res stock photography and images - Page 17 - Alamy
Differential denaturation of serum proteome reveals a significant amount of hidden information in complex mixtures of proteins. - Abstract - Europe PMC
Gian CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI | Oncologia | Research profile
Immunological validation of α2MB, Apo E and Apo A1 as potential diagnostic biomarkers.
10+ "Giancarlo Antonini" profiles | LinkedIn
10+ "Giancarlo Antonini" profiles | LinkedIn
Ecco i finalisti del Premio Roma di letteratura - Il Faro Online
Differential Denaturation of Serum Proteome Reveals a Significant Amount of Hidden Information in Complex Mixtures of Proteins | PLOS ONE
Manuel Mugnai - Opponents | Transfermarkt
Dr. Fadlo R. Khuri, MD | New York, NY | Oncologist | US News Doctors
ioo;;-~~ ." - ,
Il caso clinico Archivi - infoMELANOMA
Visual Clustering of Transcriptomic Data from Primary and Metastatic Tumors – Dependencies and Novel Pitfalls
Dr. Gian Carlo Antonini Cappellini, oncologo | ClickDoc.it
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma | Journal of Translational Medicine | Full Text
Differential Denaturation of Serum Proteome Reveals a Significant Amount of Hidden Information in Complex Mixtures of Proteins | PLOS ONE
Differential Denaturation of Serum Proteome Reveals a Significant Amount of Hidden Information in Complex Mixtures of Proteins | PLOS ONE
Gian CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI | Oncologia | Research profile
